✦ LIBER ✦

Impact of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in a sexually active population of North American women

✍ Scribed by Eliav Barr; Christine K. Gause; Oliver M. Bautista; Radha A. Railkar; Lisa C. Lupinacci; Ralph P. Insinga; Heather L. Sings; Richard M. Haupt

Book ID: 113432597
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 185 KB
Volume: 198
Category: Article
ISSN: 1097-6868
DOI: 10.1016/j.ajog.2007.09.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, immunogenicity, and efficacy of

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women

✍ Gonzalo Perez; Eduardo Lazcano-Ponce; Mauricio Hernandez-Avila; Patricia J. Garc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 103 KB

## Abstract The prevalence of HPV infection in Latin America is among the highest in the world. A quadrivalent (types 6/11/16/18) human papillomavirus L1 virus‐like‐particle vaccine has been shown to be 95–100% effective in preventing HPV 6/11/16/18‐related cervical and genital disease in women naï

Induction of immune memory following adm

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

✍ Sven-Eric Olsson; Luisa L. Villa; Ronaldo L.R. Costa; Carlos A. Petta; Rosires P 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 442 KB

The impact of a quadrivalent human papil

The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24

✍ S Majewski; FX Bosch; J. Dillner; O-E Iversen; SK Kjaer; N Muñoz; S-E Olsson; J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Immunogenicity of a Prophylactic Quadriv

Immunogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescent Transplant Recipients

✍ Gomez-Lobo, V.; Moudgil, A.; Whyte, T.; Kaufman, S.; Torres, C.; Mete, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Prophylactic quadrivalent human papillom

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

✍ Luisa L Villa; Ronaldo LR Costa; Carlos A Petta; Rosires P Andrade; Kevin A Ault 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 109 KB

Comparison of the Immunogenicity and Rea

Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women

✍ Block, S. L.; Nolan, T.; Sattler, C.; Barr, E.; Giacoletti, K. E.D.; Marchant, C 📂 Article 📅 2006 🏛 American Academy of Pediatrics 🌐 English ⚖ 409 KB